Health BehaviorDABQNCT06467058
Convergent Validity of DABQ Questionnaire
A study testing DABQ questionnaire versus Actigraph as reference method in people with Health Behavior, run by University Ghent at 1 site in Belgium.
Trial summary
Time-use epidemiology is a rapidly growing research area that aims to understand how individuals allocate their time to various activities throughout the day. Accurate assessment of daily activity behaviors, such as sleep, sedentary behavior (SB), light physical activity (LPA), and moderate to vigorous physical… Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Health Behavior
- What is being tested?
- DABQ questionnaire versus Actigraph as reference method
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 100 participants
- Where
- 1 siteBelgium
- Study dates
- 30 Sep 2023to 1 Jul 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Adults between 18 and 65 years old
Who cannot join
- Physical (e.g. amputations, paralysis, recovering from stroke, osteoarthritis conditions that obstruct daily functioning
- Cognitive (e.g. dementia, psychological disorders) conditions that obstruct daily functioning
- Major medical (e.g. Chronic respiratory diseases, heart failure, cardiovascular diseases) conditions that obstruct daily functioning
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Convergent Validity of the DABQ Questionnaire With the Actigraph as Reference Method to Assess 24-hour Movement Behaviors Among Adults
Time-use epidemiology is a rapidly growing research area that aims to understand how individuals allocate their time to various activities throughout the day. Accurate assessment of daily activity behaviors, such as sleep, sedentary behavior (SB), light physical activity (LPA), and moderate to vigorous physical activity (MVPA), is crucial for studying the associations between activity patterns and health outcomes. To gather this information, researchers often rely on self-report questionnaires and objective measures, such as accelerometers, to provide a comprehensive understanding of individuals' activity levels.
Recently, a validated questionnaire known as the Daily Activity Behavior Questionnaire (DABQ) has been developed. In a study comparing DABQ estimates with the activPAL4 accelerometer (as the reference method), good results regarding absolute agreement and consistency were obtained for sleep duration (ICC 0.6), while the absolute agreement and consistency for SB, LPA, and MVPA estimates was lower (ICC ranging from 0.22-0.47).
Read more
It should be noted that this study acknowledges the limitation of not treating the data as compositional data. Compositional data analysis accounts for the relative distribution of different activities and avoids the assumption of independence between behaviors. Additionally, the activPAL4 accelerometer used as the reference method in the study had its own strengths and weaknesses when compared to other objective measures, such as the Actigraph. Where ActivPAL4 is more used to differentiate between sitting and standing, Actigraph is able to better classify activity intensities. Moreover, as recommended in different research, I use the Actigraph in my PhD to objectively asses 24-hour movement behaviors.
Given these considerations, the aim of this study is to validate the DABQ against the Actigraph as the reference method. Furthermore, this study aims to analyze the data as compositional data, which would provide a more comprehensive understanding of the interrelatedness of behaviors. The hypothesis is that there will be moderate convergent validity between the DABQ and Actigraph, allowing for accurate assessment of sleep duration, SB, LPA, and MVPA. By establishing the validity of the DABQ and considering the data as compositional, researchers can utilize this questionnaire in time-use epidemiology studies, which could be seen as an easy to use and cost-effective measurement method.
- Conditions
- Health Behavior
- Being tested
- DABQ questionnaire versus Actigraph as reference method
- Keywords
- convergent validity, Actigraph, Daily activity behavior questionnaire, 24-hour movement behaviors
- Medical subject headings
- Health Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
DABQ questionnaire versus Actigraph as reference methodDevice
In this study, participants will have one contact session with the researcher, which will be held either at Ghent University Hospital or at the participants' home. During this session, participants will be provided with an accelerometer device and two questionnaires (to be filled in after wearing the Actigraph), namely the Daily Activity Behavior Questionnaire (DABQ) and general information questionnaire.
The participants will receive an Actigraph wGT3X+BT accelerometer which will be worn for seven consecutive days. Instructions will be given on how to wear the accelerometer (e.g. during the day at the hip and during the night at the wrist). At the end of this week, the participants will fill in both questionnaires. After wearing the accelerometer for seven consecutive days and filling in both questionnaires, the researcher will visit the participants to collect the devices, or the participants will send them back by postal package.
| Study group | Role | What they receive |
|---|---|---|
| Adults | Other | In this study, participants will have one contact session with the researcher, which will be held either at Ghent University Hospital or at the participants' home. During this session, participants will be provided with an accelerometer device and two questionnaires (to be filled in after wearing the Actigraph), namely the Daily Activity Behavior Questionnaire (DABQ) and general information questionnaire.
The participants will receive an Actigraph wGT3X+BT accelerometer which will be worn for seven consecutive days. Instructions will be given on how to wear the accelerometer (e.g. during the day at the hip and during the night at the wrist). At the end of this week, the participants will fill in both questionnaires. After wearing the accelerometer for seven consecutive days and filling in both questionnaires, the researcher will visit the participants to collect the devices, or the participants will send them back by postal package. Receives: Device: DABQ questionnaire versus Actigraph as reference method |
What is being measured
The primary outcome is the main question the study is designed to answer.
Total 24-hour movement behaviors collected by the Actigraph GT3X+BT
The Actigraph GT3X+BT will objectively collect time spent in sleep, sedentary behavior and physical activity. This device will be worn be the participants during 7 consecutive days (at night at their non-dominant wrist and during the day at their right hip).
Measured: Through study completion, an average of 2 weeks
Total 24-hour movement behaviors collected by the Daily Activity Behavior Questionnaire (DABQ)
This questionnaire will subjectively collect time spent in sleep, sedentary behavior and physical activity. This questionnaire will be filled in at the end of the 7 days wearing the Actigraph mentioned in outcome 1.
Measured: Through study completion, an average of 2 weeks
Convergent validity between time spent in 24-hour movement behaviors collected by the Actigraph GT3X+BT and DABQ
Intraclass correlation coefficient (95% confidence intervals) and pearson/spearman correlation will be used to measure the convergent validity and intermeasurement reliability. This method allows the comparison between self-reported use of time and the device measured use of time for each behavior separately.
Measured: Through study completion, an average of 2 weeks
Secondary outcomes (12)
Participant characteristics "sex" potentially explaining biases in reporting 24-hour movement behaviors.
Interaction effects between difference in measurement (Actigraph versus DABQ) and participant characteristics are explored to better interpret discrepancies between questionnaire- and accelerometer-assessed physical activity, ensuring more reliable and generalizable findings.
Measured: Through study completion, an average of 2 weeks
Participant characteristics "age" potentially explaining biases in reporting 24-hour movement behaviors.
Interaction effects between difference in measurement (Actigraph versus DABQ) and participant characteristics are explored to better interpret discrepancies between questionnaire- and accelerometer-assessed physical activity, ensuring more reliable and generalizable findings.
Measured: Through study completion, an average of 2 weeks
Participant characteristics "body mass index" potentially explaining biases in reporting 24-hour movement behaviors.
Interaction effects between difference in measurement (Actigraph versus DABQ) and participant characteristics are explored to better interpret discrepancies between questionnaire- and accelerometer-assessed physical activity, ensuring more reliable and generalizable findings.
Measured: Through study completion, an average of 2 weeks
Participant characteristics "family situation" potentially explaining biases in reporting 24-hour movement behaviors.
Interaction effects between difference in measurement (Actigraph versus DABQ) and participant characteristics are explored to better interpret discrepancies between questionnaire- and accelerometer-assessed physical activity, ensuring more reliable and generalizable findings.
Measured: Through study completion, an average of 2 weeks
Participant characteristics "children" potentially explaining biases in reporting 24-hour movement behaviors.
Interaction effects between difference in measurement (Actigraph versus DABQ) and participant characteristics are explored to better interpret discrepancies between questionnaire- and accelerometer-assessed physical activity, ensuring more reliable and generalizable findings.
Measured: Through study completion, an average of 2 weeks
Participant characteristics "educational level" potentially explaining biases in reporting 24-hour movement behaviors.
Interaction effects between difference in measurement (Actigraph versus DABQ) and participant characteristics are explored to better interpret discrepancies between questionnaire- and accelerometer-assessed physical activity, ensuring more reliable and generalizable findings.
Measured: Through study completion, an average of 2 weeks
Participant characteristics "sedentary job" potentially explaining biases in reporting 24-hour movement behaviors.
Interaction effects between difference in measurement (Actigraph versus DABQ) and participant characteristics are explored to better interpret discrepancies between questionnaire- and accelerometer-assessed physical activity, ensuring more reliable and generalizable findings.
Measured: Through study completion, an average of 2 weeks
Participant characteristics "net family income" potentially explaining biases in reporting 24-hour movement behaviors.
Interaction effects between difference in measurement (Actigraph versus DABQ) and participant characteristics are explored to better interpret discrepancies between questionnaire- and accelerometer-assessed physical activity, ensuring more reliable and generalizable findings.
Measured: Through study completion, an average of 2 weeks
Participant characteristics "smoking status" potentially explaining biases in reporting 24-hour movement behaviors.
Interaction effects between difference in measurement (Actigraph versus DABQ) and participant characteristics are explored to better interpret discrepancies between questionnaire- and accelerometer-assessed physical activity, ensuring more reliable and generalizable findings.
Measured: Through study completion, an average of 2 weeks
Participant characteristics "feasibility of wearing the Actigraph" potentially explaining biases in reporting 24-hour movement behaviors.
Interaction effects between difference in measurement (Actigraph versus DABQ) and participant characteristics are explored to better interpret discrepancies between questionnaire- and accelerometer-assessed physical activity, ensuring more reliable and generalizable findings.
Measured: Through study completion, an average of 2 weeks
Participant characteristics "annoying to wear the Actigraph" potentially explaining biases in reporting 24-hour movement behaviors.
Interaction effects between difference in measurement (Actigraph versus DABQ) and participant characteristics are explored to better interpret discrepancies between questionnaire- and accelerometer-assessed physical activity, ensuring more reliable and generalizable findings.
Measured: Through study completion, an average of 2 weeks
Participant characteristics "consistency of wearing the Actigraph" potentially explaining biases in reporting 24-hour movement behaviors.
Interaction effects between difference in measurement (Actigraph versus DABQ) and participant characteristics are explored to better interpret discrepancies between questionnaire- and accelerometer-assessed physical activity, ensuring more reliable and generalizable findings.
Measured: Through study completion, an average of 2 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Jun 2024
- Study start30 Sep 2023
- Primary completion1 Jul 2024
- Study completion1 Jul 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Health BehaviorStudies of the same condition, open and under way.
- More trials run by University GhentThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- convergent validity of a daily activity behavior questionnaire with the actigraph as reference among healthy adults
- Masking
- None (open label)
- Enrolment
- 100 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Ghent
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Marieke De Craemer, Principal investigator, University Ghent
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06467058
- Sponsor's protocol ID
- ONZ-2023-0384
- Acronym
- DABQ
- Status last verified
- Aug 2024
- First submitted
- 26 Feb 2024
- Last updated
- 9 Aug 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Aug 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Convergent Validity of the DABQ Questionnaire With the Actigraph as Reference Method to Assess 24-hour Movement Behaviors Among Adults
- ClinicalTrials.gov ID
- NCT06467058
- Acronym / sponsor ID
- DABQ / ONZ-2023-0384
- Conditions
- Health Behavior
- Keywords
- convergent validity, Actigraph, Daily activity behavior questionnaire, 24-hour movement behaviors
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 100 participants (actual)
- Lead sponsor
- University GhentUniversity, hospital or other
- Study start
- 30 Sep 2023 (actual)
- Primary completion
- 1 Jul 2024 (actual)
- Study completion
- 1 Jul 2024 (actual)
- First posted
- 20 Jun 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Time-use epidemiology is a rapidly growing research area that aims to understand how individuals allocate their time to various activities throughout the day. Accurate assessment of daily activity behaviors, such as sleep, sedentary behavior (SB), light physical activity (LPA), and moderate to vigorous physical activity (MVPA), is crucial for studying the associations between activity patterns and health outcomes. To gather this information, researchers often rely on self-report questionnaires and objective measures, such as accelerometers, to provide a comprehensive understanding of individuals' activity levels.
Recently, a validated questionnaire known as the Daily Activity Behavior Questionnaire (DABQ) has been developed. In a study comparing DABQ estimates with the activPAL4 accelerometer (as the reference method), good results regarding absolute agreement and consistency were obtained for sleep duration (ICC 0.6), while the absolute agreement and consistency for SB, LPA, and MVPA estimates was lower (ICC ranging from 0.22-0.47).
It should be noted that this study acknowledges the limitation of not treating the data as compositional data. Compositional data analysis accounts for the relative distribution of different activities and avoids the assumption of independence between behaviors. Additionally, the activPAL4 accelerometer used as the reference method in the study had its own strengths and weaknesses when compared to other objective measures, such as the Actigraph. Where ActivPAL4 is more used to differentiate between sitting and standing, Actigraph is able to better classify activity intensities. Moreover, as recommended in different research, I use the Actigraph in my PhD to objectively asses 24-hour movement behaviors.
Given these considerations, the aim of this study is to validate the DABQ against the Actigraph as the reference method. Furthermore, this study aims to analyze the data as compositional data, which would provide a more comprehensive understanding of the interrelatedness of behaviors. The hypothesis is that there will be moderate convergent validity between the DABQ and Actigraph, allowing for accurate assessment of sleep duration, SB, LPA, and MVPA. By establishing the validity of the DABQ and considering the data as compositional, researchers can utilize this questionnaire in time-use epidemiology studies, which could be seen as an easy to use and cost-effective measurement method.
Study design
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- convergent validity of a daily activity behavior questionnaire with the actigraph as reference among healthy adults
| Arm | Type | Receives |
|---|---|---|
| Adults | Other | Device: DABQ questionnaire versus Actigraph as reference methodIn this study, participants will have one contact session with the researcher, which will be held either at Ghent University Hospital or at the participants' home. During this session, participants will be provided with an accelerometer device and two questionnaires (to be filled in after wearing the Actigraph), namely the Daily Activity Behavior Questionnaire (DABQ) and general information questionnaire. The participants will receive an Actigraph wGT3X+BT accelerometer which will be worn for seven consecutive days. Instructions will be given on how to wear the accelerometer (e.g. during the day at the hip and during the night at the wrist). At the end of this week, the participants will fill in both questionnaires. After wearing the accelerometer for seven consecutive days and filling in both questionnaires, the researcher will visit the participants to collect the devices, or the participants will send them back by postal package. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Adults between 18 and 65 years old
Key exclusion criteria (3 listed)
- Physical (e.g. amputations, paralysis, recovering from stroke, osteoarthritis conditions that obstruct daily functioning
- Cognitive (e.g. dementia, psychological disorders) conditions that obstruct daily functioning
- Major medical (e.g. Chronic respiratory diseases, heart failure, cardiovascular diseases) conditions that obstruct daily functioning
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| DABQ questionnaire versus Actigraph as reference methodIn this study, participants will have one contact session with the researcher, which will be held either at Ghent University Hospital or at the participants' home. During this session, participants will be provided with an accelerometer device and two questionnaires (to be filled in after wearing the Actigraph), namely the Daily Activity Behavior Questionnaire (DABQ) and general information questionnaire. The participants will receive an Actigraph wGT3X+BT accelerometer which will be worn for seven consecutive days. Instructions will be given on how to wear the accelerometer (e.g. during the day at the hip and during the night at the wrist). At the end of this week, the participants will fill in both questionnaires. After wearing the accelerometer for seven consecutive days and filling in both questionnaires, the researcher will visit the participants to collect the devices, or the participants will send them back by postal package. | Device | Adults |
Primary outcome
Total 24-hour movement behaviors collected by the Actigraph GT3X+BT
Time frame: Through study completion, an average of 2 weeks
The Actigraph GT3X+BT will objectively collect time spent in sleep, sedentary behavior and physical activity. This device will be worn be the participants during 7 consecutive days (at night at their non-dominant wrist and during the day at their right hip).
Total 24-hour movement behaviors collected by the Daily Activity Behavior Questionnaire (DABQ)
Time frame: Through study completion, an average of 2 weeks
This questionnaire will subjectively collect time spent in sleep, sedentary behavior and physical activity. This questionnaire will be filled in at the end of the 7 days wearing the Actigraph mentioned in outcome 1.
Convergent validity between time spent in 24-hour movement behaviors collected by the Actigraph GT3X+BT and DABQ
Time frame: Through study completion, an average of 2 weeks
Intraclass correlation coefficient (95% confidence intervals) and pearson/spearman correlation will be used to measure the convergent validity and intermeasurement reliability. This method allows the comparison between self-reported use of time and the device measured use of time for each behavior separately.
12 secondary outcomes
Participant characteristics "sex" potentially explaining biases in reporting 24-hour movement behaviors.
Time frame: Through study completion, an average of 2 weeks
Participant characteristics "age" potentially explaining biases in reporting 24-hour movement behaviors.
Time frame: Through study completion, an average of 2 weeks
Participant characteristics "body mass index" potentially explaining biases in reporting 24-hour movement behaviors.
Time frame: Through study completion, an average of 2 weeks
Participant characteristics "family situation" potentially explaining biases in reporting 24-hour movement behaviors.
Time frame: Through study completion, an average of 2 weeks
Participant characteristics "children" potentially explaining biases in reporting 24-hour movement behaviors.
Time frame: Through study completion, an average of 2 weeks
Participant characteristics "educational level" potentially explaining biases in reporting 24-hour movement behaviors.
Time frame: Through study completion, an average of 2 weeks
Participant characteristics "sedentary job" potentially explaining biases in reporting 24-hour movement behaviors.
Time frame: Through study completion, an average of 2 weeks
Participant characteristics "net family income" potentially explaining biases in reporting 24-hour movement behaviors.
Time frame: Through study completion, an average of 2 weeks
Participant characteristics "smoking status" potentially explaining biases in reporting 24-hour movement behaviors.
Time frame: Through study completion, an average of 2 weeks
Participant characteristics "feasibility of wearing the Actigraph" potentially explaining biases in reporting 24-hour movement behaviors.
Time frame: Through study completion, an average of 2 weeks
Participant characteristics "annoying to wear the Actigraph" potentially explaining biases in reporting 24-hour movement behaviors.
Time frame: Through study completion, an average of 2 weeks
Participant characteristics "consistency of wearing the Actigraph" potentially explaining biases in reporting 24-hour movement behaviors.
Time frame: Through study completion, an average of 2 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Aug 2024.
Related trials for Health Behavior
Recruiting
Effect of a Fermented Dairy Protein With Prebiotic Fiber on GI Complaints
Digestive Health, Quality of Life
Not yet recruitingObservational study
A Natural History of Cardiometabolic Disease Among US Bhutanese: Developing the Cross-Sectional Bhutanese Community of Central Ohio Health Study to Understand Acculturation as Synergizing Socioenvironmental and Biobehavioral Risk Factors Propagating ...
Cardiometabolic Risk Factors, Mental Health
Recruiting
Impact of a Structured Wellness Behavioral Intervention on Quality of Life in NMOSD
Neuromyelitis Optica Spectrum Disorder (NMOSD)
Active, not recruiting
NYUCI-ES: Psychosocial Intervention to Improve Health Outcomes for Chinese and Korean ADRD Caregivers
Dementia Caregivers, Diabetes
Enrolling by invitation
Intervention to Reduce HIV Related Stigma Among Pregnant and Postpartum Women
HIV, HIV - Human Immunodeficiency Virus
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Marieke De Craemer principal investigator
University Ghent
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing DABQ questionnaire versus Actigraph as reference method in people with Health Behavior, run by University Ghent at 1 site in Belgium.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Total 24-hour movement behaviors collected by the Actigraph GT3X+BT (time frame: Through study completion, an average of 2 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Aug 2024.